ExLibris header image
SFX Logo
Title: Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
Source:

Plos One [1932-6203] Isakova Sivak, Irina yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Hoa, L.K. K. "Development of pandemic influenza vaccine production capacity in Viet Nam." Vaccine 29.S1 (2011). Link to SFX for this item
2. Dhere, R. "A pandemic influenza vaccine in India : From strain to sale within 12 months." Vaccine 29.Suppl. 1 (2011): 16-. Link to SFX for this item
3. Assi, T. "How influenza vaccination policy may affect vaccine logistics." Vaccine 30.30 (2012): 4517-4523. Link to SFX for this item
4. Suhardono M, M. "Establishment of pandemic influenza vaccine production capacity at Bio Farma, Indonesia." Vaccine 29 Suppl 1.S1 (2011): -5. Link to SFX for this item
5. Sambhara, S. "H5N1 Avian Influenza: Preventive and Therapeutic Strategies Against a Pandemic." Annual Review of Medicine 61.1 (2010): 187-198. Link to Full Text for this item Link to SFX for this item
6. Tree, J A A. "Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains." Vaccine 19.25-26 (2001): 3444-50. Link to Full Text for this item Link to SFX for this item
7. Brandt, S. "Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine." Vaccine 29.44 (2011): 7696-7703. Link to SFX for this item
8. Rudenko L, L. "Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries." Vaccine 29 Suppl 1.1 (2011). Link to SFX for this item
9. Smith, Marc n. "Vaccine production, distribution, access, and uptake." Lancet 378, no. 9789.9789 (2011): 428-38. Link to SFX for this item
10. Mittal, K. "Pandemic influenza A (H1N1) 2009 vaccine: An update." Indian journal of medical microbiology 29.1 (2011): 13-8. Link to SFX for this item
11. CHALUMEAU, H P P. "VACCINE MANUFACTURE AT THE TIME OF A PANDEMIC INFLUENZA." European Journal of Epidemiology 10.4 (1994): 487-490. Link to Full Text for this item Link to SFX for this item
12. Peetermans, J. "Production, quality control and characterization of an inactivated hepatitis A vaccine." Vaccine 10 Suppl 1 (1992): -101. Link to SFX for this item
13. Fan, S. "Valproic acid enhances gene expression from viral gene transfer vectors." Journal of Virological Methods 125.1 (2005): 23-33. Link to SFX for this item
14. Gerdil, C. "The annual production cycle for influenza vaccine." Vaccine 21.16 (2003): 1776-9. Link to SFX for this item
15. McLennan, S. "Reflections on the influenza vaccination of healthcare workers." Vaccine 28.51 (2010): 8061-8064. Link to SFX for this item
16. d'Onofrio, A. "Vaccine demand driven by vaccine side effects : dynamic implications for SIR diseases." Journal of theoretical biology 264.2 (2010): 237-252. Link to SFX for this item
17. Bishai, David M. "Vaccine storage practices in pediatric offices." Pediatrics 89.2 (1992): 193-196. Link to SFX for this item
18. Hanvoravongchai, P. "Pandemic influenza preparedness and health systems challenges in Asia: Results from rapid analyses in 6 Asian countries." BMC public health 10.1 (2010): 322-322. Link to Full Text for this item Link to SFX for this item
19. Uyeki, Timothy M. "Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues." Clinical infectious diseases 49.2 (2009): 279-90. Link to SFX for this item
20. Hoelscher, M. "Vaccines against epidemic and pandemic influenza." Expert Opinion on Drug Delivery 5.10 (2008): 1139-1157. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced